Table 1.
Baseline demographics, characteristics, and smoking history
| Variable | Bupropion SR + CM (n = 37) | Bupropion SR + Non-CM (n = 36) | Placebo + CM (n = 29) | Placebo + Non-CM (n = 32) | p-value* |
|---|---|---|---|---|---|
| Age | 18.4 (1.9) | 18.4 (1.9) | 18.1 (1.9) | 19.0 (1.8) | 0.26 |
| % Male | 56.8 | 61.1 | 62.1 | 53.1 | 0.89 |
| % White | 94.6 | 86.1 | 89.7 | 84.4 | 0.55 |
| % with history of ADHD | 32.4 | 38.9 | 34.5 | 34.4 | 0.95 |
| % in school | 67.6 | 75.0 | 69.0 | 68.8 | 0.90 |
| % that live with a smoker | 70.3 | 66.7 | 62.1 | 62.5 | 0.90 |
| Prior Quit Attempts (SD) | 3.3 (4.2) | 2.6 (2.0) | 1.8 (1.3) | 3.1 (2.6) | 0.20 |
| Years of Smoking | 4.2 (2.3) | 3.7 (2.1) | 4.1 (2.3) | 4.2 (2.0) | 0.73 |
| Baseline Cigarettes per Day | 11.3 (6.3) | 11.5 (8.1) | 11.2 (6.4) | 9.1 (4.5) | 0.61 |
| FTND (Nicotine Dependence) Score (range 0 – 10) | 4.0 (2.3) | 4.1 (2.3) | 4.1 (2.0) | 4.5 (2.3) | 0.89 |
| Baseline Expired Carbon Monoxide Level (ppm) | 7.8 (5.4) | 7.9 (5.0) | 9.2 (8.3) | 8.8 (6.9) | 0.99 |
| Baseline Urine Cotinine Level (ng/mL) | 1023.9 (911.8) | 1056.3 (659.6) | 964.9 (627.6) | 1059.4 (774.2) | 0.89 |
*
all p-values are 2-sided Kruskal-Wallis p-values or Fisher Exact Values